Back to Search
Start Over
Newer antifungal therapy for emerging fungal pathogens.
- Source :
-
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2003 Mar; Vol. 7 (1), pp. 5-20. - Publication Year :
- 2003
-
Abstract
- As the number of immunocompromised patients increases, there is a concomitant increase in the number and diversity of fungal infections. Fungi that were once considered harmless or contaminants are now pathogenic in the immunocompromised host. Often these emerging pathogens are indistinguishable from the more familiar fungal infections; however, they are generally more recalcitrant to conventional antifungal therapies. With the antifungal armamentarium now expanding, the clinician now has many more options for these difficult-to-treat mycoses. We review many of the newer antifungal agents (second-generation triazoles, echinocandins, etc.) as therapeutic options for the recently emerging fungal pathogens.
- Subjects :
- Animals
Antifungal Agents pharmacology
Fungi classification
Fungi drug effects
Fungi isolation & purification
Fungi physiology
Humans
Mycoses microbiology
Antifungal Agents therapeutic use
Communicable Diseases, Emerging drug therapy
Communicable Diseases, Emerging microbiology
Mycoses drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1201-9712
- Volume :
- 7
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- Publication Type :
- Academic Journal
- Accession number :
- 12718805
- Full Text :
- https://doi.org/10.1016/s1201-9712(03)90037-3